BUY VIOXX ONLINE

VIOXX CLAIM

VIOXX LITIGATION

VIOXX AND HEART DISEASE

VIOXX ROFECOXIB

Google

vioxx heart attack is Powered by Blogger


Links to Site

Monday, May 7, 2007

Vioxx heart attack - Bextra Withdrawal Could Be Just the Beginning for Pfizer

L' alarms at cause ofshouldnt of reports/ratios of FDA; the agency indicates that itstudies less than 50 incidents of blindness in the patients who employa drug which was employed by more than twenty million people since herintroduction seven years ago. The search for FDA indicates less aboutthe probability of blindness in the patients than it makes about theagencys proper concern concerning its reputation. The FDA requirescorrectly on the rigorous test of drugs before they reach the marketin the name of public safety. But this coin has two sides, and vioxx heart attack thereare those which indicate that the agency is too fast to approvepotentially dangerous drugs and vioxx heart attack others which indicate that the agencysexamining the rather complete isnt. By adding the fuel to fire beingthe recent notes obtained starting from the employees of Merck whopropose that the company was aggressively Vioxx sale though theirpersonnel of sales knew that drug was potentiallydangereuse.
Il cannot y have any bond between Viagra and vioxx heart attack the blindness of the whole, because the form of sudden blindness pledto be caused by use of Viagra is common to the kinds of patients whohave the dysfunction rectile. The FDA is to be just careful, as theyshould be. Other tests will determine if there is a real bond. Thepart probably to be suffered immediately is Pfizer, like theshareholders, already worried by lawsuits of Bextra, led the stockexchange of actions low immediately on the release of the news ofViagra. The sales will probably decrease, also, as patient which arenow accustomed to have knowledge of drugs being withdrawn from themarket can launch far from the product until other tests are carriedout. That could present an enormous income for Pfizer, as they sellcurrently approximately $2 billion value of Viagra every year. Thebusinesses of drug are advantageous, but like any businesses, comewith risks. This year, it would seem that Pfizer obtains a double doseof bad m decine.